S. Nakagawa et al., EVIDENCE FOR SERUM FACTORS MODULATING ANTIBODY-PRODUCTION IN NORMAL AND MACULAR MICE, Biological & pharmaceutical bulletin, 16(6), 1993, pp. 534-537
The macular mutant mouse is a model of Menkes' kinky hair disease, whi
ch is characterized by a deficiency of ceruloplasmin in the serum. In
hemizygotic mice (ml/y), the antibody production against sheep red blo
od cells (SRBC) was decreased. Treatment with normal (+/y) mouse serum
increased in a dose-dependent manner the antibody response of ml/y mo
use spleen cells in vitro. However, +/y mouse serum had no effect on /y mouse spleen cells, even at high doses up to 5%. In contrast, ml/y
mouse serum decreased antibody production in +/y mouse spleen cells in
a dose-dependent manner. Antibody production in +/y mouse spleen cell
s decreased with time, after pretreatment with ml/y mouse serum. Howev
er, serum from ml/y mice injected with ceruloplasmin did not decrease
antibody production in +/y mouse spleen cells but rather increased it
in ml/y mouse spleen cells. Ceruloplasmin had no effect on the product
ion of antibodies against SRBC in ml/y and +/y mouse spleen cells in v
itro. These findings suggest that one or more enhancers of antibody pr
oduction exist in normal mouse serum and that one or more suppressors
of normal antibody production exist in ml/y mouse serum. It is propose
d that the activities of these factors in serum may be regulated by ce
ruloplasmin.